Acne more likely in transgender patients receiving testosterone

Counselling is crucial given the increased risk of suicide and depression in transgender and gender diverse patients, researchers say

Transgender patients who receive masculinising hormone therapy are significantly more likely to develop acne than cisgender men or women, as well as transgender patients not receiving testosterone, a new study suggests.

Conversely, those receiving feminising, gender-affirming therapy have a similar or lower risk compared to cisgender individuals, according to researchers at The Fenway Institute in Boston, US.

The authors suggest that patients commencing testosterone therapy should be counselled about the increased acne risk given its detrimental